Abstract: Methods, systems, and apparatuses for creating collections of associated accounts for a migration process. An example system includes a processing device and memory that stores accounts in accordance with a first email, identity or file domain. The processing device may create a collection of related accounts stored in accordance with a first email, identity or file domain based on active directory information of the stored accounts and may migrate information included in the collection of accounts into a second email, identity or file domain. The collection includes one or more first-level accounts that are identified as having a relationship with a predefined root account based on a delegation attribute.

Abstract: A display tray with multiple side panels attached to one another to form tray sides. The display tray includes a tray surface having an area defined by the first, second, third, and fourth four side panels. Additionally, the display tray includes multiple corner columns, with a corner column located in each corner of the tray. Each corner column upwardly extends from the tray surface and is sturdy enough to support the stacking of another design tray on top.

Abstract: A knockdown that can be assembled into a display tray, such as that of a PDQ style tray, having a bottom, front, rear and opposing side panels, and an alignment panel having an alignment portion and a connection portion divided by a fold line. The alignment panel provides for automatic alignment of the rear and side panels from the knockdown form to the display tray form. A display tray is also provided.

Abstract: Augmented or synergized anti-inflammatory constructs are disclosed including terpenes covalently conjugated with other anti-inflammatory molecules such as nonsteroidal anti-inflammatory drugs, vanilloids, amino acids and polyamines; and anti-inflammatory molecules covalently conjugated with specific amino acids. For the latter, further conjugation with a choline bioisostere further augments the anti-inflammatory activity.

Abstract: Three unique subtypes of N-hydroxyamides and N-hydroxycarbamates containing both the vanilloid moiety (4-hydroxy-3-methoxybenzyl) and a lipophilic aliphatic moiety. Also disclosed are direct syntheses of these vanilloid fatty hydroxamates. The compounds possess inhibitory activity against the enzymes fatty acid amide hydrolase (FAAH) and matrix metallo-proteinase 9 (MMP-9). In addition, these substances bind to the calcium channel protein TRPV1 and inhibit vesicant-induced inflammation in skin and cornea. The compounds have utility in treating topical or systemic inflammatory processes in the skin and/or eye.

Abstract: A container knockdown assembly capable of opening into an erected container assembly. The knockdown includes an unopened outer sleeve having first and second outer side panels opposing and substantially parallel to one another when in the knockdown form, and an unopened inner sleeve having first and second inner side panels opposing and substantially parallel to one another when in the knockdown form. The inner sleeve is secured within the outer sleeve in a positional relationship of the assembled container. A cutout is formed in a section of one of the outer corners of the outer sleeve to expose at least a portion of a corner of the inner corner. A container formed from such a knockdown is also provided.

Abstract: Methods, systems, and apparatuses for creating collections of associated accounts for a migration process. An example system includes a processing device and memory that stores accounts in accordance with a first email, identity or file domain. The processing device may create a collection of related accounts stored in accordance with a first email, identity or file domain based on active directory information of the stored accounts and may migrate information included in the collection of accounts into a second email, identity or file domain. The collection includes one or more first-level accounts that are identified as having a relationship with a predefined root account based on a delegation attribute.

Abstract: Augmented or synergized anti-inflammatory constructs are disclosed including terpenes covalently conjugated with other anti-inflammatory molecules such as nonsteroidal anti-inflammatory drugs, vanilloids, amino acids and polyamines; and anti-inflammatory molecules covalently conjugated with specific amino acids. For the latter, further conjugation with a choline bioisostere further augments the anti-inflammatory activity.

Abstract: A container knockdown assembly capable of opening into an erected container assembly. The knockdown includes an unopened outer sleeve having first and second outer side panels opposing and substantially parallel to one another when in the knockdown form, and an unopened inner sleeve having first and second inner side panels opposing and substantially parallel to one another when in the knockdown form. The inner sleeve is secured within the outer sleeve in a positional relationship of the assembled container. A cutout is formed in a section of one of the outer corners of the outer sleeve to expose at least a portion of a corner of the inner corner. A container formed from such a knockdown is also provided.

Abstract: A container assembly having an inner container and an outer cover fixedly attached to one another. The inner container has multiple sidewalls for forming the inner container sidewalls and has a bottom forming flap attached thereto. The outer cover has multiple cover sidewalls that fit over the inner container sidewalls to enclose the inner container. At least one attachment member attached to and extending from the outer cover is attached to the bottom forming flap, thereby fixedly attaching the inner container to the outer container. The attachment member can be separated from the container outer cover to allow removal of the outer cover from the inner container without marring the finish of the outside face of the sidewalls of the inner container. A knockdown assembly that is erectable to form the container assembly is also provided.

Abstract: A display tray with multiple side panels attached to one another to form tray sides. The display tray includes a tray surface having an area defined by the first, second, third, and fourth four side panels. Additionally, the display tray includes multiple corner columns, with a corner column located in each corner of the tray. Each corner column upwardly extends from the tray surface and is sturdy enough to support the stacking of another design tray on top.

Abstract: A container assembly having an inner container and an outer cover fixedly attached to one another. The inner container has multiple sidewalls for forming the inner container sidewalls and has a bottom forming flap attached thereto. The outer cover has multiple cover sidewalls that fit over the inner container sidewalls to enclose the inner container. At least one attachment member attached to and extending from the outer cover is attached to the bottom forming flap, thereby fixedly attaching the inner container to the outer container. The attachment member can be separated from the container outer cover to allow removal of the outer cover from the inner container without marring the finish of the outside face of the sidewalls of the inner container. A knockdown assembly that is erectable to form the container assembly is also provided.

Abstract: A container knockdown assembly capable of opening into an erected container assembly. The knockdown includes an unopened outer sleeve having first and second outer side panels opposing and substantially parallel to one another when in the knockdown form, and an unopened inner sleeve having first and second inner side panels opposing and substantially parallel to one another when in the knockdown form. The inner sleeve is secured within the outer sleeve in a positional relationship of the assembled container. A cutout is formed in a section of one of the outer corners of the outer sleeve to expose at least a portion of a corner of the inner corner. A container formed from such a knockdown is also provided.

Abstract: This application relates to pharmacologically-active vanilloid compounds which are useful for the treatment of various anti-inflammatory states characterized by inhibition of FAAH, such as, Alzheimer's dementia, Parkinson's disease, depression, pain, rheumatoid arthritis, pathophysiology of mood disorders, multiple sclerosis, and inflammation, or antagonism of TRPV1, such as, for example, Huntington's disease, hypertension, arthritis, allergic airway inflammation, Crohn's disease, ulcerative colitis, and neuropathic pain.

Abstract: Three unique subtypes of N-hydroxyamides and N-hydroxycarbamates containing both the vanilloid moiety (4-hydroxy-3-methoxybenzyl) and a lipophilic aliphatic moiety. Also disclosed are direct syntheses of these vanilloid fatty hydroxamates. The compounds possess inhibitory activity against the enzymes fatty acid amide hydrolase (FAAH) and matrix metallo-proteinase 9 (MMP-9). In addition, these substances bind to the calcium channel protein TRPV1 and inhibit vesicant-induced inflammation in skin and cornea. The compounds have utility in treating topical or systemic inflammatory processes in the skin and/or eye.

Abstract: This application relates to pharmacologically-active vanilloid compounds which are useful for the treatment of various anti-inflammatory states characterized by inhibition of FAAH, such as, Alzheimer's dementia, Parkinson's disease, depression, pain, rheumatoid arthritis, pathophysiology of mood disorders, multiple sclerosis, and inflammation, or antagonism of TRPV1, such as, for example, Huntington's disease, hypertension, arthritis, allergic airway inflammation, Crohn's disease, ulcerative colitis, and neuropathic pain.

Abstract: This invention provides compounds having the structural formula: wherein: R1 is an acyl or sulfonyl group, R2 is an acyl group selected from the group consisting of acyl groups derived from cycloaliphatic, aromatic or heterocyclic monocarboxylic acids, imidazolylcarbonyl and triazolylcarbonyl, and R3 is hydrogen or an amino-protecting group, a stereoisomer thereof, a solvate thereof, or a salt thereof, being useful as anti-inflammatory agents and anti-cancer agents.

Abstract: A container having multiple wall panels forming container sides, the container having at least first and second wall panels that meet at a first corner. The container is assembleable from a flat or knockdown state to an opened or assembled state. A first inner panel is attached to a first wall panel, the first inner panel having an end spaced from the first corner. A slidable corner support is attached to the end of the first inner panel and extends towards the second wall panel. When the container is assembled from the knockdown state, the slidable corner support moves away from the first corner to form a support member that can help support a container stacked on top and prevent nesting.

Abstract: A container assembly having an inner container and an outer cover that fits over the inner container. The inner container is positioned within the outer cover. The outer cover includes an overlay formed in the outer cover sidewalls by a tear line allowing the overlay to be detached from the outer cover. An adhesive secures the inner container and the outer cover together with the adhesive being provided between the inner container and the overlay so that the overlay can detach from the outer cover and remain attached to the inner container over the adhesive when the outer cover is removed from the inner container. A knockdown assembly that can be erected into a container assembly is also provided.

Abstract: This invention provides compounds having the structural formula: wherein: R1 is an acyl or sulfonyl group, R2 is an acyl group selected from the group consisting of acyl groups derived from cycloaliphatic, aromatic or heterocyclic monocarboxylic acids, imidazolylcarbonyl and triazolylcarbonyl, and R3 is hydrogen or an amino-protecting group, a stereoisomer thereof, a solvate thereof, or a salt thereof, being useful as anti-inflammatory agents and anti-cancer agents.